Cauterisation versus fibrin glue for conjunctival autografting in primary pterygium surgery (CAGE CUP): study protocol of a randomised controlled trial.
Mladen Lešin, Martina Paradžik, Josipa Marin Lovrić...
https://pubmed.ncbi.nlm.nih.gov/29950464Actively Recruiting
Led by University of Split, School of Medicine · Updated on 2022-11-02
164
Participants Needed
1
Research Sites
87 weeks
Total Duration
U
University of Split, School of Medicine
Lead Sponsor
U
University Hospital of Split
Collaborating Sponsor
Pterygium is a noncancerous growth of the conjunctival tissue over the cornea that can progress to cause vision problems, eye movement restrictions, chronic inflammation, and cosmetic issues. This clinical trial evaluates and compares two methods for securing conjunctival autografts during primary pterygium surgery: cauterization and fibrin glue. The study is randomized and controlled to assess which method may influence recurrence rates and other outcomes. The two interventions studied are cauterization, where a bipolar cutter is used to secure the graft with controlled cauterizing wraps, and fibrin glue, where a fiber adhesive is prepared and applied to fix the graft. The fibrin glue preparation takes about 10 to 15 minutes and is performed by a nurse. Both procedures aim to secure the conjunctival autograft during surgery to prevent recurrence. Participants will be followed for 180 days after surgery to monitor the recurrence of pterygium, surgical time, complication rates, astigmatism caused by pterygium, ocular surface condition, and postoperative symptoms such as discomfort, tearing, pain, and foreign body sensation. Pain and economic analyses will also be assessed at various time points including 7, 30, and 180 days after surgery. The study includes triple masking and random allocation to study groups.
CONDITIONS
Cauterization Versus fibrin Glue for Conjunctival Autografting in Primary Pterygium Surgery
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Day of surgery
Participants undergo primary pterygium surgery with conjunctival autografting using either cauterization or fibrin glue to secure the graft.
1 surgery visit (in-person)
Duration - 180 days
Participants are monitored for surgical outcomes, complications, pain, and ocular surface condition after surgery.
Visits at 7, 30, and 180 days post-surgery
Total: 1 location
1
University Hospital Split
Split, Croatia, 21000
Actively Recruiting
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Mladen Lešin, Martina Paradžik, Josipa Marin Lovrić...
https://pubmed.ncbi.nlm.nih.gov/29950464